secwatch.observer — SEC 8-K summary
======================================

Issuer:     PALVELLA THERAPEUTICS, INC. (PVLA)
CIK:        0001583648
Form:       8-K
Filed at:   2024-04-18T23:59:59+00:00
Accession:  0001437749-24-012442
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 3.03, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pieris Pharmaceuticals announces 1-for-80 reverse stock split to regain Nasdaq compliance
--------------------------------------------------------------------------------

- Reverse stock split at ratio 1-for-80 effective 5:00 pm ET on April 22, 2024; begins trading split-adjusted on April 23 under symbol PIRS.
- Outstanding shares reduced from 98,935,025 to approximately 1,236,688; authorized common shares decreased from 300M to 3.75M.
- Split aims to raise bid price above $1.00 per share and meet Nasdaq Listing Rule 5550(a)(2) minimum bid price requirement.
- No fractional shares issued; fractional interests rounded up to one whole share. CUSIP changes to 720795202.
- All outstanding options, warrants, and preferred stock conversion terms adjusted proportionately per their governing documents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583648/000143774924012442/0001437749-24-012442-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583648/000143774924012442/pirs20240401_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-012442

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer